Current progress of 1,2,3-triazole hybrids as EGFR inhibitors for cancer therapy – a literature review

Hussam Elddin Nabeih Khasawneh, Hesham M. Hassan, Amal Ali Alharbi, Wesam Taher Almagharbeh, Raed Fanoukh Aboqader Al-Aouadi, Kirandeep Kaur, Ramya Maranan, Hadeer M. Farhan, Hamada Hashem, Mariam M. Hassan, Stefan Bräse and Ahmed Al-Emam

RSC Adv., 2025, 15, 40998
DOI: 10.1039/D5RA03819G

Expanding the therapeutic applications of PARP inhibitors in cancer by targeting receptor tyrosine kinases

Amirsajad Jafari, Shirin Fathi, Fatemeh Moosavi and Omidreza Firuzi

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026, 1881, 189552
DOI: 10.1016/j.bbcan.2026.189552

Mechanistic Insights into the [3+2] Cycloaddition Reaction of Azomethine Ylides with Methyl Vinyl Ketone in the Triplet Excited State: A Molecular Electron Density Theory Study

Luis R. Domingo, Patricia Pérez and Assem Barakat

Eur J Org Chem, 2025, 28
DOI: 10.1002/ejoc.202500241

Eco‐Friendly Strategies for Synthesizing Spirooxindoles and Pyranopyrazoles: A Comprehensive Review

Shersing K. Padavi, Suraj P. Vasave and Dipak B. Patil

ChemistrySelect, 2026, 11
DOI: 10.1002/slct.202504793

Design, synthesis, and anticancer evaluation of spirooxindole–1,2,3-triazole hybrids as potent VEGFR-2 inhibitors

Assem Barakat, Moayad Abdullah Alwehaibi, Abdulmajeed Abdullah Alayyaf, M. Ali, Muhanna K. Al-Muhanna, Mohamed W. Attwa, Hessa H. Al-Rasheed, Mohamed S. Nafie, Sherif Ramadan, Esraa M. Fathi and Marwan Emara

Bioorganic Chemistry, 2025, 167, 109278
DOI: 10.1016/j.bioorg.2025.109278

Indenoquinoxaline‐Based Spiro‐Heterocycles: Synthesis, Structural Characterization, MEDT Study, and Dual Inhibition of Kinase‐Related Enzymes EGFR and VEGFR2

Abdulmajeed Abdullah Alayyaf, Abdullah Saleh Alamary, Mohammad Shahidul Islam, M. Ali, Assem Barakat, Ahmed Bari, Luis R. Domingo, Khaled M. Darwish, Mona A. Khamis, Marwan Emara, Amany M. Elshamy, Tebyan O. Mirgany and Mohamed S. Nafie

Chemistry & Biodiversity, 2026, 23
DOI: 10.1002/cbdv.202501597

Targeting EGFR With Indole Derivatives: Recent Advances and Therapeutic Perspectives

Tanishq Verma, Anuradha Mehra and Amit Mittal

Chemistry & Biodiversity, 2026, 23
DOI: 10.1002/cbdv.202502968

Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition

Konstantinos A. Ouzounthanasis, Chiara Bosetti, Juho Alaviuhkola, Saurabh S. Dhakar, Christiana Mantzourani, Maroula G. Kokotou, Demetrios Kanetidis, Lari Lehtiö and Alexandros E. Koumbis

J. Med. Chem., 2025
DOI: 10.1021/acs.jmedchem.5c02481

Medicinal Chemistry of PARP Inhibitors: Structural Insights and Mechanistic Implications for Oncology

Kumari Kajal, Raj Kumar Narang and Rohit Bhatia

ChemistrySelect, 2026, 11
DOI: 10.1002/slct.202504272

Synthesis, X-ray structure, Hirshfeld analysis, molecular docking and anticancer evaluation of 1,2,3-triazole-pyrazolopyrimidine hybrids

Tareq Q. Alshargabi, Maged W. Helmy, Saied M. Soliman, Matti Haukka, Assem Barakat, Mohamed Hagar, Mohamed Gaber Marie, Shymaa Abdullah Mohamed, Doaa Hassan Osman and Mohamed G. Bekhit

Journal of Molecular Structure, 2025, 1345, 143040
DOI: 10.1016/j.molstruc.2025.143040

Synthesis of New Bis‐1,2,3‐Triazoles Possessing High Anti‐Proliferative Activities and Electrochemical Interaction Studies With dsDNA

Cagla Efeoglu, Riza Serttas, Selenay Sadak, Suat Erdogan, Bengi Uslu, Abdulilah Ece and Yahya Nural

ChemistrySelect, 2025, 10
DOI: 10.1002/slct.202504640